irasia.com - Investor Relations Asia Pacific
HOME

Pharmaxis Ltd

Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2010-December-20
  • Bronchitol EU Marketing Authorisation Update (in PDF)
  • 2010-December-16
  • Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial (in PDF)
  • 2010-December-15
  • Pharmaxis Holds Pre-NDA Meeting with FDA for Bronchitol (in PDF)
  • 2010-December-13
  • Bronchitol Recommended for Approval by Australian Advisory Committee (in PDF)
  • 2010-December-7
  • Phase II Trial of ASM8 in Asthma Commences (in PDF)
  • 2010-October-22
  • Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results (in PDF)
  • 2010-October-20
  • 2010 Annual General Meeting Chairman's Address (in PDF)
  • 2010-October-20
  • Pharmaxis Chief Executive Officer Resumes Office (in PDF)
  • 2010-October-12
  • Pharmaxis Quarterly Investor Conference Call (in PDF)
  • 2010-October-6
  • US Food and Drug Administration Approves Aridol (in PDF)
  • 2010-August-31
  • Pharmaxis Announces Agreement for European Marketing of Bronchitol (in PDF)
  • 2010-July-20
  • Quarterly Report to Shareholders and Investor Conference Call (in PDF)
  • 2010-July-8
  • Update on Pharmaxis Chief Executive Officer (in PDF)
  • 2010-June-22
  • Pharmaxis Investor Conference Call (in PDF)
  • 2010-June-22
  • Pharmaxis Announces Results for Second Phase III Trial of Bronchitol in Cystic Fibrosis (in PDF)
  • 2010-May-17
  • Pharmaxis Announces Sustained Benefit in Cystic Fibrosis Following Long Term Bronchitol Treatment (in PDF)
  • 2010-April-27
  • Pharmaxis Provides FDA Resubmission for Aridol U.S. Marketing Application (in PDF)
  • 2010-April-14
  • Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis (in PDF)
  • 2010-April-12
  • Pharmaxis Investor Conference Call (in PDF)
  • 2010-March-11
  • Pharmaxis Completes Phase II Clinical Study with ASM8 in Asthma Patients (in PDF)
  • 2010-February-9
  • Pharmaxis Completes Acquisition of Canadian Company TOPIGEN Pharmaceuticals Inc. (in PDF)
  • 2010-February-9
  • Pharmaxis Completes Clinical Trial with the Antifibrotic Agent, PXS25 (in PDF)
  • 2010-January-22
  • Pharmaxis Investor Conference Call (in PDF)
  • 2010-January-12
  • Pharmaxis to Acquire Canadian Company TOPIGEN Pharmaceuticals Inc. (in PDF)
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases
  • 2006
  • 2006 Press Releases
  • 2005
  • 2005 Press Releases
  • 2004
  • 2004 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2023 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.